Mandel-Brehm Josh insider trades
Mandel-Brehm Josh has filed 9 Form 4s with the SEC that we hold, for Camp4 Therapeutics Corp (CAMP) (Chief Executive Officer, Director) and ProMIS Neurosciences Inc. (PMN) (Director). Across all of them we count 2 purchases worth $20.8K and 0 sales worth $0 reported on Form 4. In the last 12 months: 1 purchase ($10.8K) and 0 sales ($0). The largest single trade was a purchase of 6,551 shares of Camp4 Therapeutics Corp worth $10.8K, dated 2026-08-03. The first filing on our record is dated 2024-10-07 and the latest 2026-08-05.
Camp4 Therapeutics Corp (CAMP)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-09-11 | P, purchase reported on Form 4 | 6,060 | $10.0K | 2025-09-11 |
| 2026-08-03 | P, purchase reported on Form 4 | 6,551 | $10.8K | 2026-08-05 |
ProMIS Neurosciences Inc. (PMN)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1927058) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms